Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5.
about
Viral vector-based influenza vaccines.A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).Virus-vectored influenza virus vaccines.Severe acute respiratory infection in children in a densely populated urban slum in Kenya, 2007-2011.Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.Regulation of Viral RNA Synthesis by the V Protein of Parainfluenza Virus 5Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge.A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoproteinInfluence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza A virus in mice.RNA-based viral vectors.Establishment and characterization of a telomerase-immortalized canine bronchiolar epithelial cell line.A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after In Vitro and In Vivo Passage.Isolation and genomic characterization of a canine parainfluenza virus type 5 strain in China.Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice.Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys.The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement.Parainfluenza virus 5-vectored vaccines against human and animal infectious diseases.
P2860
Q30390938-36DB621D-8DF3-41BC-A177-8F2F5759036EQ33690612-AC7704CB-BFF4-467A-8E8C-FFB3B0513328Q34102268-EE0FC102-7962-4184-B198-06DBD2E7AA75Q35154420-FD0A202A-6BB0-4A1F-9A1D-9B15E690CA2BQ35214413-57A5BC34-CC9A-4284-8B9F-19A657DF83DBQ36281163-E0A0E34A-0DCE-465A-A45A-C431CABA609EQ36506905-8F281D10-AA58-406D-852B-D7B7C6C7C2BEQ36667958-3467DCF9-D5D1-4D29-86CD-D1EF8BBF3436Q36827280-57445F6F-1397-4F7D-940E-903E368FC672Q36827388-AC320C7B-A15E-4577-97F2-87196BE32B8BQ37123456-76B1803E-7E26-490F-B855-57977CFCED62Q38266413-84CE0D38-CCE4-490A-91B6-B8FE3DAB1E6AQ38855280-10DB9243-7BD6-4967-9602-903C25A59F07Q38905050-F1FEFA69-BEB2-4700-94DC-62F60EED0AB8Q40107054-2703FCA9-78B2-406B-892F-7C1CAC77171DQ40222160-3404F1F7-CF34-4F76-9BFA-9BBF694C26A5Q40916919-7C3C0528-4636-44B1-8B84-030038F23B35Q41696601-E4044381-27FB-40A1-87D9-E795E2432F01Q42174484-A24E3316-480B-43C1-96B8-37B5A800518EQ47556502-17D55A3E-771D-43D3-AB22-F73E9F524E0C
P2860
Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@ast
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@en
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@nl
type
label
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@ast
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@en
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@nl
prefLabel
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@ast
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@en
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@nl
P2093
P2860
P1433
P1476
Evaluating a parainfluenza vir ...... against parainfluenza virus 5.
@en
P2093
Balazs Rada
Gregory W Salyards
Stephen B Harvey
Zhenhai Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0050144
P407
P577
2012-11-20T00:00:00Z